News
Lilly points to long-lasting weight loss with orforglipron
Lilly breaks new ground for oral GLP-1 agonists with data showing it can help patients keep weight off after treatment with injectable therapies.
R&D
Europe has the tools to fight superbugs. Let’s use them.
Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.
News
Takeda plans filings for Sotyktu rival on new psoriasis data
Takeda intends to file for approval of its oral psoriasis therapy zasocitinib next year, with Bristol Myers Squibb's Sotyktu in its sights.
R&D
FDA’s emerging framework to reduce animal testing: Implicati...
Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.
News
As year-end nears, pharma groups plump up their pipelines
Bristol Myers Squibb, Sanofi, Pfizer, Roche, and Yarrow Bioscience all added to their pipelines this week in an end-of-year licensing deal flurry.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
